Leerink partners, TD Cowen, and William Blair initiated coverage and set ratings for Kailera Therapeutics.

The entities involved

• TD Cowen →

  American investment bank

  • Wendy's is being analyzed for privatization prospects by TD Cowen amid Middle East war driving commodity price surges.Wed 22:01
  • Datadog saw institutional investment changes tracked by the SEC and received a buy rating from TD Cowen.Sun 09:24
• Leerink partners →

  U.S. investment bank

  • Summit seeks FDA approval for its drug, which was presented at the ASCO meeting. The company is developing ivonescimab with Akeso.Sun 19:40
  • Intuitive Surgical received a Buy rating from Leerink partners, citing increased da Vinci placements and potential benefits from Trump-era tariffs.Sat 07:31

Related events

• Citigroup reissued a market outperform rating and Leerink Partners began coverage on Rapport Therapeutics.Oct 9
• TD Cowen initiated coverage on Northern Trust shares on October 8, 2026.Oct 8
• Financial firms, including RBC, TD Cowen, Leerink Partners, and Morgan Stanley, raised price targets and provided coverage for Vertex Pharmaceuticals.Oct 20
• TD Cowen upgraded Maze Therapeutics shares to a strong-buy rating, with coverage reported by MarketBeat.Oct 20
• TD Cowen initiated coverage on Citizens Financial Group shares.Oct 8